# ARSL

## Overview
The ARSL gene encodes the enzyme arylsulfatase L, a member of the sulfatase family, which is involved in the hydrolysis of sulfate esters. This enzyme plays a pivotal role in the development and maintenance of bone and cartilage, making it essential for proper skeletal formation. Arylsulfatase L is characterized by its sulfatase domain, which is crucial for its enzymatic activity, and undergoes post-translational modifications such as glycosylation that influence its function and stability. Mutations in the ARSL gene are linked to X-linked chondrodysplasia punctata (CDPX1), a disorder affecting bone and cartilage development, highlighting the clinical significance of this gene (Sorrentino2022New; Woods2022Uniparental).

## Structure
The ARSL gene encodes the enzyme arylsulfatase L, which plays a crucial role in the hydrolysis of sulfate esters, particularly in bone and cartilage composition. The ARSL protein contains a significant sulfatase domain, with the N-terminal sulfatase domain being particularly important for its function. Within this domain, the Ser410 residue is critical, as it is located at the internal interface between the conserved N- and C-terminal sulfatase domains. This residue is essential for the proper folding and function of the protein (Woods2022Uniparental).

The ARSL protein may undergo post-translational modifications, such as glycosylation, which is common for proteins involved in extracellular processes. These modifications can affect the protein's stability, localization, and activity. The ARSL gene may also produce splice variant isoforms, which are different forms of the protein resulting from alternative splicing of mRNA. These isoforms can have variations in their structure and function, potentially influencing the enzyme's role in different tissues or developmental stages (Sorrentino2022New).

The ARSL protein's structure, including its primary, secondary, tertiary, and quaternary structures, is crucial for its enzymatic activity and interaction with other cellular components. However, specific details on these structural aspects are not provided in the available context.

## Clinical Significance
Mutations in the ARSL gene are associated with X-linked chondrodysplasia punctata (CDPX1), a rare skeletal disorder characterized by abnormalities in bone and cartilage development. CDPX1 is marked by features such as shortened distal digits, epiphyseal stippling, and nasomaxillary hypoplasia. The severity of the condition can vary significantly, with some individuals experiencing mild skeletal abnormalities, while others may suffer from severe complications like spinal cord stenosis, hearing loss, and respiratory issues (Zhang2021Prenatal; Woods2022Uniparental).

A unique case of CDPX1 was reported where the condition resulted from maternal uniparental disomy of the X chromosome, leading to a homozygous mutation in the ARSL gene. This mode of inheritance is rare and had not been previously documented for CDPX1 (Woods2022Uniparental). The specific mutation identified was ARSL NM_000047.2: c.1227_1228delinsAT p.(Ser410Cys), which likely disrupts the folding and function of the enzyme arylsulfatase E, encoded by the ARSL gene (Woods2022Uniparental).

Alterations in ARSL expression or function may also impact other metabolic pathways, potentially contributing to additional disorders, although specific conditions beyond CDPX1 are not detailed in the provided context.


## References


[1. (Zhang2021Prenatal) Li Zhang, Haoran Hu, Desheng Liang, Zhuo Li, and Lingqian Wu. Prenatal diagnosis in a fetus with x-linked recessive chondrodysplasia punctata: identification and functional study of a novel missense mutation in arse. Frontiers in Genetics, September 2021. URL: http://dx.doi.org/10.3389/fgene.2021.722694, doi:10.3389/fgene.2021.722694. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fgene.2021.722694)

[2. (Sorrentino2022New) Nicolina Cristina Sorrentino, Maximiliano Presa, Sergio Attanasio, Vincenzo Cacace, Martina Sofia, Aamir Zuberi, Jennifer Ryan, Somdatta Ray, Igor Petkovic, Karthikeyan Radhakrishnan, Lars Schlotawa, Andrea Ballabio, Cathleen Lutz, and Nicola Brunetti‐Pierri. New mouse models with hypomorphic sumf1 variants mimic attenuated forms of multiple sulfatase deficiency. Journal of Inherited Metabolic Disease, 46(2):335–347, December 2022. URL: http://dx.doi.org/10.1002/jimd.12577, doi:10.1002/jimd.12577. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/jimd.12577)

[3. (Woods2022Uniparental) Emily Woods, Michael Yates, Farah Kanani, and Meena Balasubramanian. Uniparental disomy as a mechanism for x-linked chondrodysplasia punctata. Clinical Dysmorphology, 31(3):132–135, March 2022. URL: http://dx.doi.org/10.1097/mcd.0000000000000419, doi:10.1097/mcd.0000000000000419. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1097/mcd.0000000000000419)